Table 1.

Clinical characteristics of study subjects

N = 86	Without prostaglandin analogue (N = 44)	With prostaglandin analogue (N = 42)	P value
Age (years)	66.67 ± 5.79	66.98 ± 10.83	0.88
Gender, male/female	20/24	18/24	0.81
Spherical equivalent	−2.18 ± 3.41	−2.31 ± 3.37	0.86
Central corneal thickness (μm)	547.23 ± 21.12	544.44 ± 50.85	0.79
Axial length (mm)	23.31 ± 2	23.44 ± 1.61	0.85
Duration of prostaglandin analogue (months)	–	57.76 ± 30.81